GlassScriptPhysician profile
Alfe R Garperio
NPI 1104366178
$4,986.36
in general payments reported to CMS, 2019-2025
25 companies · $739 in 2025
The $739 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $949 · 2022: $917 · 2023: $1,332 · 2024: $1,049 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,120.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $1,681.61 | 2021-2025 | Ztlido |
| Abbott Laboratories | $592.64 | 2022-2025 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $446.89 | 2021-2025 | Relistor |
| Valinor Pharma, LLC | $404.18 | 2023-2025 | Movantik |
| Abbvie INC. | $349.59 | 2021-2024 | |
| Kowa Pharmaceuticals America, INC. | $245.36 | 2022-2023 | Seglentis |
| Nevro Corp. | $221.39 | 2021-2024 | Senza |
| Allergan, INC. | $160.21 | 2021 | |
| Forte Bio-Pharma LLC | $114.52 | 2022-2024 | Prolate, Nalocet |
| Redhill Biopharma INC. | $108.61 | 2021-2022 | |
| Boston Scientific Corporation | $103.07 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Ibsa Pharma INC. | $87.34 | 2023 | Tirosint, Licart |
| Collegium Pharmaceutical, INC. | $82.09 | 2021-2022 | |
| Virtus Pharmaceuticals LLC | $67.49 | 2021 | |
| Si-Bone, INC. | $53.76 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $40.17 | 2023 | Intracept |
| Avanos Medical | $37.82 | 2025 | Standard Rf Disposables |
| Tonix Medicines, INC. | $31.52 | 2025 | Tonmya |
| Medtronic, INC. | $29.09 | 2024 | Intellis Adaptivestim |
| Globus Medical, INC. | $28.80 | 2025 | Omnia |
| Averitas Pharma INC. | $25.22 | 2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $21.40 | 2025 | |
| Horizon Therapeutics Plc | $19.48 | 2022 | |
| Arbor Pharmaceuticals, INC. | $19.41 | 2021 | |
| Grt US Holding, INC. | $14.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfe Garperio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.